Carlsmed Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash & Equivalents	46.34	85.89	40.23	7.37
Short-Term Investments	42.98	24	-	-
Cash & Short-Term Investments	89.32	109.89	40.23	7.37
Cash Growth	166.07%	173.20%	445.65%	-
Accounts Receivable	13.78	11.36	6.77	3.17
Inventory	2.28	1.85	1	0.58
Other Current Assets	4.22	3.57	1.37	0.65
Total Current Assets	109.6	126.67	49.35	11.77
Net Property, Plant & Equipment	8.35	3.31	1.9	2.24
Other Long-Term Assets	0.25	0.13	0.57	0.02
Total Assets	118.2	130.12	51.82	14.02
Accounts Payable	3.7	4.48	2.41	1.69
Accrued Expenses	7.99	9.05	5.96	3.6
Current Portion of Long-Term Debt	-	-	-	1.84
Current Portion of Leases	0.7	0.75	0.45	0.31
Total Current Liabilities	12.4	14.28	8.82	7.44
Long-Term Debt	15.38	15.35	15.41	7.47
Long-Term Leases	5.83	1.32	1.32	1.77
Other Long-Term Liabilities	0.35	0.31	0.68	0.1
Total Long-Term Liabilities	21.56	16.97	17.41	9.34
Total Liabilities	33.96	31.25	26.23	16.78
Additional Paid-in Capital	204.27	199.67	0.54	0.78
Accumulated Other Comprehensive Income	-0.02	-	-	-
Retained Earnings	-120.01	-100.81	-71.17	-46.91
Total Common Shareholders' Equity	84.25	98.87	-70.63	-46.13
Minority Interest	-	-	96.23	43.38
Shareholders' Equity	84.25	98.87	25.6	-2.75
Total Liabilities & Equity	118.2	130.12	51.82	14.02
Total Debt	21.92	17.41	17.18	11.39
Net Cash (Debt)	67.41	92.48	23.05	-4.02
Net Cash Growth	324.88%	301.30%	-	-
Net Cash Per Share	2.65	6.50	5.67	-1.03
Book Value	84.25	98.87	-70.63	-46.13
Book Value Per Share	3.31	6.95	-17.37	-11.87
Tangible Book Value	84.25	98.87	-70.63	-46.13
Tangible Book Value Per Share	3.31	6.95	-17.37	-11.87

SEC Filings: 10-K · 10-Q